SB00241 - An Act Concerning The Office Of Health Strategy's Recommendations Regarding 340b Program Transparency.
Connecticut - 2024 General Assembly
Introduced byPublic Health
Last updated 7 months ago
0 Co-Sponsors
To require entities authorized to participate in the federal 340B Drug Pricing Program to report to the Health Systems Planning Unit of the Office of Health Strategy certain information regarding the program, including (1) aggregated acquisition costs, (2) aggregated payment information, (3) the number of claims for prescription drugs under the program, and (4) if the entity is a hospital, the national drug code number for the fifty most frequently dispensed prescription drugs by the hospital under the program.
STATUS
Introduced
Verifications Required
You must be a verified voter to do that.
No Thanks, I'll do it later
Verify your identity now